0|chunk|The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
0	4	8 role	Chemical	CHEBI_50906
0	77	110 dipeptidyl peptidase-4 inhibitors	Chemical	CHEBI_68612
0	100	110 inhibitors	Chemical	CHEBI_35222
0	127	138 linagliptin	Chemical	CHEBI_68610
0	CHEBI-CHEBI	CHEBI_50906	CHEBI_68612
0	CHEBI-CHEBI	CHEBI_50906	CHEBI_35222
0	CHEBI-CHEBI	CHEBI_50906	CHEBI_68610
0	CHEBI-CHEBI	CHEBI_68612	CHEBI_35222
0	CHEBI-CHEBI	CHEBI_68612	CHEBI_68610
0	CHEBI-CHEBI	CHEBI_35222	CHEBI_68610

1|chunk|Emerging evidence suggests that dipeptidyl peptidase-4 (DPP-4) inhibitors used to treat type 2 diabetes may have nephroprotective effects beyond the reduced renal risk conferred by glycemic control. DPP-4 is a ubiquitous protein with exopeptidase activity that exists in cell membrane-bound and soluble forms.
1	63	73 inhibitors	Chemical	CHEBI_35222
1	221	228 protein	Chemical	CHEBI_16541
1	CHEBI-CHEBI	CHEBI_35222	CHEBI_16541

